• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

青少年炎症性肠病的黏膜细菌菌群和黏液层厚度。

Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.

机构信息

Department of Pediatrics, Gastroenterology and Nutrition, Polish-American Children's Hospital, Jagiellonian University Medical College, 265 Wielicka Str., 30-663 Cracow, Poland.

出版信息

World J Gastroenterol. 2009 Nov 14;15(42):5287-94. doi: 10.3748/wjg.15.5287.

DOI:10.3748/wjg.15.5287
PMID:19908336
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2776855/
Abstract

AIM

To assess the mucosa-associated bacterial microflora and mucus layer in adolescents with inflammatory bowel disease (IBD).

METHODS

Sixty-one adolescents (mean age 15 years, SD+/-4.13) were included in the study. Intestinal biopsies from inflamed and non-inflamed mucosa of IBD patients and from controls with functional abdominal pain were cultured under aerobic and anaerobic conditions. The number of microbes belonging to the same group was calculated per weight of collected tissue. The mucus thickness in frozen samples was measured under a fluorescent microscope.

RESULTS

The ratios of different bacterial groups in inflamed and non-inflamed mucosa of IBD patients and controls were specific for particular diseases. Streptococcus spp. were predominant in the inflamed mucosa of Crohn's disease (CD) patients (80% of all bacteria), and Lactobacillus spp. were predominant in ulcerative colitis patients (90%). The differences were statistically significant (P=0.01-0.001). Lower number of bifidobacteria was observed in the whole IBD group. A relation was also found between clinical and endoscopic severity and decreased numbers of Lactobacillus and, to a lesser extent, of Streptococcus in biopsies from CD patients. The mucus layer in the inflamed sites was significantly thinner as compared to controls (P=0.0033) and to non-inflamed areas in IBD patients (P=0.031).

CONCLUSION

The significantly thinner mucosa of IBD patients showed a predominance of some aerobes specific for particular diseases, their numbers decreased in relation to higher clinical and endoscopic activity of the disease.

摘要

目的

评估炎症性肠病(IBD)青少年的黏膜相关细菌菌群和黏液层。

方法

纳入 61 名青少年(平均年龄 15 岁,标准差+/-4.13)进行研究。对 IBD 患者的炎症和非炎症黏膜以及功能性腹痛对照者的肠道活检进行需氧和厌氧培养。根据采集组织的重量计算同组微生物的数量。在荧光显微镜下测量冷冻样本中的黏液厚度。

结果

IBD 患者的炎症和非炎症黏膜中不同细菌群的比例因特定疾病而异。在克罗恩病(CD)患者的炎症黏膜中,链球菌属(Streptococcus spp.)占主导地位(所有细菌的 80%),而溃疡性结肠炎患者以乳杆菌属(Lactobacillus spp.)为主(90%)。差异具有统计学意义(P=0.01-0.001)。整个 IBD 组双歧杆菌的数量也较低。还发现 CD 患者的临床和内镜严重程度与活检中乳杆菌和链球菌数量减少有关,而链球菌的数量减少程度较小。与对照者(P=0.0033)和 IBD 患者的非炎症部位相比,炎症部位的黏液层明显更薄(P=0.031)。

结论

IBD 患者的黏膜明显变薄,表现出某些特定疾病的优势需氧菌,其数量与疾病的临床和内镜活动度增加有关。

相似文献

1
Mucosal bacterial microflora and mucus layer thickness in adolescents with inflammatory bowel disease.青少年炎症性肠病的黏膜细菌菌群和黏液层厚度。
World J Gastroenterol. 2009 Nov 14;15(42):5287-94. doi: 10.3748/wjg.15.5287.
2
The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.与对照组相比,炎症性肠病患者的肠道黏液层中含有大量细菌。
Gastroenterology. 1999 Nov;117(5):1089-97. doi: 10.1016/s0016-5085(99)70393-8.
3
Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.肠道微生物群组成失衡可能参与炎症性肠病的发病机制。
Int J Med Microbiol. 2008 Jul;298(5-6):463-72. doi: 10.1016/j.ijmm.2007.07.016. Epub 2007 Sep 25.
4
Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease.患有炎症性肠病的儿科患者的肠道相关细菌微生物群。
Gut. 2006 Dec;55(12):1760-7. doi: 10.1136/gut.2005.078824. Epub 2006 Apr 28.
5
Comparative study of the intestinal mucus barrier in normal and inflamed colon.正常结肠与炎症结肠中肠道黏液屏障的比较研究
Gut. 2007 Mar;56(3):343-50. doi: 10.1136/gut.2006.098160. Epub 2006 Aug 14.
6
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.用于研究正常和炎症状态下人结肠上皮细胞代谢与免疫功能的体外模型的开发、验证及应用
Dan Med J. 2015 Jan;62(1):B4973.
7
Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease.炎症性肠病中直肠黏膜相关细菌菌群的分子特征分析
Inflamm Bowel Dis. 2005 May;11(5):481-7. doi: 10.1097/01.mib.0000159663.62651.4f.
8
Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.炎症性肠病患者切除的肠黏膜和内镜活检组织的直接组织等电聚焦蛋白质谱分析。
Clin Invest Med. 1992 Feb;15(1):49-59.
9
High prevalence of Mycoplasma pneumoniae in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls.炎症性肠病患者和对照者肠道黏膜活检中肺炎支原体的高流行率。
Dig Dis Sci. 2001 Nov;46(11):2529-35. doi: 10.1023/a:1012352626117.
10
Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.糖皮质激素和饮食对犬炎症性肠病黏膜微生物群的影响。
PLoS One. 2019 Dec 30;14(12):e0226780. doi: 10.1371/journal.pone.0226780. eCollection 2019.

引用本文的文献

1
Deciphering the microbiome-metabolome landscape of an inflammatory bowel disease inception cohort.解析炎症性肠病起始队列的微生物组-代谢组图谱。
Gut Microbes. 2025 Dec;17(1):2527863. doi: 10.1080/19490976.2025.2527863. Epub 2025 Jul 18.
2
Presence of viable gram-positive bacteria in blood of patients with inflammatory bowel disease is not affected by treatment.炎症性肠病患者血液中存活的革兰氏阳性菌的存在不受治疗影响。
Sci Rep. 2025 Jun 25;15(1):20283. doi: 10.1038/s41598-025-07535-z.
3
Inorganic dietary nanoparticles in intestinal barrier function of inflammatory bowel disease: allies or adversaries?无机膳食纳米颗粒在炎症性肠病肠道屏障功能中的作用:盟友还是对手?
Front Immunol. 2025 Apr 9;16:1563504. doi: 10.3389/fimmu.2025.1563504. eCollection 2025.
4
Importance of Lactobacilli for Human Health.乳酸杆菌对人类健康的重要性。
Microorganisms. 2024 Nov 21;12(12):2382. doi: 10.3390/microorganisms12122382.
5
Intestinal Fibrogenesis in Inflammatory Bowel Diseases: Exploring the Potential Role of Gut Microbiota Metabolites as Modulators.炎症性肠病中的肠道纤维化:探索肠道微生物群代谢产物作为调节剂的潜在作用。
Pharmaceuticals (Basel). 2024 Apr 11;17(4):490. doi: 10.3390/ph17040490.
6
Stromal BMP signaling regulates mucin production in the large intestine via interleukin-1/17.基质 BMP 信号通过白细胞介素 1/17 调节大肠中的粘蛋白产生。
Sci Adv. 2023 Oct 27;9(43):eadi1827. doi: 10.1126/sciadv.adi1827.
7
Clinical Effects of Faecal Microbiota Transplantation as Adjunctive Therapy in Dogs with Chronic Enteropathies-A Retrospective Case Series of 41 Dogs.粪便微生物群移植作为慢性肠病犬辅助治疗的临床效果——41例犬的回顾性病例系列研究
Vet Sci. 2023 Apr 3;10(4):271. doi: 10.3390/vetsci10040271.
8
Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease.吲哚丙酸:肠道微生物代谢物在宿主健康和疾病中的重要作用概述
Nutrients. 2022 Dec 28;15(1):151. doi: 10.3390/nu15010151.
9
Site-selective oral delivery of therapeutic antibodies to the inflamed colon a folic acid-grafted organic/inorganic hybrid nanocomposite system.治疗性抗体向炎症结肠的位点选择性口服递送:一种叶酸接枝的有机/无机杂化纳米复合系统
Acta Pharm Sin B. 2022 Nov;12(11):4249-4261. doi: 10.1016/j.apsb.2022.06.006. Epub 2022 Jun 10.
10
Extremely small and incredibly close: Gut microbes as modulators of inflammation and targets for therapeutic intervention.极其微小且无比紧密:肠道微生物作为炎症调节因子及治疗干预靶点
Front Microbiol. 2022 Aug 22;13:958346. doi: 10.3389/fmicb.2022.958346. eCollection 2022.

本文引用的文献

1
Recent advances in molecular approaches to gut microbiota in inflammatory bowel disease.炎症性肠病中肠道微生物群分子研究方法的最新进展
Curr Pharm Des. 2009;15(18):2066-73. doi: 10.2174/138161209788489186.
2
Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.克罗恩病与溃疡性结肠炎杯状细胞分化的差异。
Differentiation. 2009 Jan;77(1):84-94. doi: 10.1016/j.diff.2008.09.008. Epub 2008 Oct 22.
3
Mucosal vascular pattern in ulcerative colitis: observations using narrow band imaging colonoscopy with special reference to histologic inflammation.溃疡性结肠炎的黏膜血管形态:使用窄带成像结肠镜检查的观察结果,特别提及组织学炎症
Int J Colorectal Dis. 2009 May;24(5):495-501. doi: 10.1007/s00384-008-0631-9. Epub 2009 Jan 15.
4
Molecular analysis of the intestinal microflora in IBD.炎症性肠病中肠道微生物群的分子分析。
Mucosal Immunol. 2008 Nov;1 Suppl 1:S15-8. doi: 10.1038/mi.2008.54.
5
OCTN and CARD15 gene polymorphism in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者中OCTN和CARD15基因多态性
World J Gastroenterol. 2008 Aug 21;14(31):4923-7. doi: 10.3748/wjg.14.4923.
6
Immunoreactivity against Goblet cells in patients with inflammatory bowel disease.炎症性肠病患者中针对杯状细胞的免疫反应性。
Inflamm Bowel Dis. 2008 May;14(5):652-61. doi: 10.1002/ibd.20370.
7
Microbial diversity of inflamed and noninflamed gut biopsy tissues in inflammatory bowel disease.炎症性肠病中发炎和未发炎肠道活检组织的微生物多样性。
Inflamm Bowel Dis. 2007 Jun;13(6):675-83. doi: 10.1002/ibd.20101.
8
Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.炎症性肠病:发病机制的最新见解及新的治疗选择;益生菌、益生元及合生元
Int J Food Microbiol. 2007 Apr 1;115(1):1-11. doi: 10.1016/j.ijfoodmicro.2006.10.006. Epub 2006 Nov 28.
9
Abnormal microbiota composition in the ileocolonic mucosa of Crohn's disease patients as revealed by polymerase chain reaction-denaturing gradient gel electrophoresis.聚合酶链反应-变性梯度凝胶电泳揭示克罗恩病患者回结肠黏膜中异常的微生物群组成
Inflamm Bowel Dis. 2006 Dec;12(12):1136-45. doi: 10.1097/01.mib.0000235828.09305.0c.
10
Intestinal microflora in human and experimental inflammatory bowel disease.人类及实验性炎症性肠病中的肠道微生物群
Curr Opin Gastroenterol. 2001 Jul;17(4):324-30. doi: 10.1097/00001574-200107000-00005.